{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383388843818902016.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Shunnosuke Handa"}],"foaf:familyName":[{"@value":"Handa"}],"foaf:givenName":[{"@value":"Shunnosuke"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363388843818902016","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1159/000360811"},{"@type":"URI","@value":"https://www.karger.com/Article/Pdf/360811"},{"@type":"PMID","@value":"24820203"}],"notation":[{"@value":"Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1159/000360811_NINjoFCZF50bDUIlZ8YPCJzuI7E"},{"@type":"OPENAIRE","@value":"doi_dedup___::e3e151b0dc58ce9438f6c24aec4d9d17_NINjoFCZF50bDUIlZ8YPCJzuI7E"}]}